Stocks & Investing
Stocks and Investing
Stocks and Investing
Thu, January 11, 2024
[ Thu, Jan 11th 2024
] - WOPRAI
[ Thu, Jan 11th 2024
] - WOPRAI
[ Thu, Jan 11th 2024
] - WOPRAI
[ Thu, Jan 11th 2024
] - WOPRAI
[ Thu, Jan 11th 2024
] - WOPRAI
[ Thu, Jan 11th 2024
] - WOPRAI
[ Thu, Jan 11th 2024
] - WOPRAI
[ Thu, Jan 11th 2024
] - WOPRAI
[ Thu, Jan 11th 2024
] - WOPRAI
[ Thu, Jan 11th 2024
] - WOPRAI
[ Thu, Jan 11th 2024
] - WOPRAI
[ Thu, Jan 11th 2024
] - WOPRAI
[ Thu, Jan 11th 2024
] - WOPRAI
[ Thu, Jan 11th 2024
] - WOPRAI
[ Thu, Jan 11th 2024
] - WOPRAI
[ Thu, Jan 11th 2024
] - WOPRAI
[ Thu, Jan 11th 2024
] - WOPRAI
[ Thu, Jan 11th 2024
] - WOPRAI
[ Thu, Jan 11th 2024
] - WOPRAI
[ Thu, Jan 11th 2024
] - WOPRAI
[ Thu, Jan 11th 2024
] - WOPRAI
[ Thu, Jan 11th 2024
] - WOPRAI
[ Thu, Jan 11th 2024
] - WOPRAI
[ Thu, Jan 11th 2024
] - WOPRAI
[ Thu, Jan 11th 2024
] - WOPRAI
[ Thu, Jan 11th 2024
] - WOPRAI
[ Thu, Jan 11th 2024
] - WOPRAI
[ Thu, Jan 11th 2024
] - WOPRAI
Edward White Maintained (TGTX) at Strong Buy with Increased Target to $45 on, Jan 11th, 2024
Edward White of HC Wainwright & Co., Maintained "TG Therapeutics, Inc." (TGTX) at Strong Buy with Increased Target from $41 to $45 on, Jan 11th, 2024.
Edward has made no other calls on TGTX in the last 4 months.
There are 3 other peers that have a rating on TGTX. Out of the 3 peers that are also analyzing TGTX, 0 agree with Edward's Rating of Hold.
These are the ratings of the 3 analyists that currently disagree with Edward
- Eric Joseph of "JP Morgan" Maintained at Buy with Increased Target to $23 on, Wednesday, November 1st, 2023
- Matthew Andrews of "Jefferies" Maintained at Strong Buy on, Wednesday, November 1st, 2023
- Mayank Mamtani of "B. Riley Securities" Maintained at Strong Buy with Decreased Target to $24 on, Friday, October 20th, 2023
